China-based baby care products manufacturer Biostime International Holdings Inc. suffered a major loss in the stock markets following news the company is under investigation for possible anticompetitive conduct. According to reports, Biostime shares dropped up to 10 percent – its deepest drop in nearly two years – as the National Development and Reform Commission is looking into the firm for allegations of price-fixing. The case follows just months after Kweichow Moutai and Wuliangye Yibin were both fined by regulators for setting minimum retail prices, say reports.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Boeing to Sell Key Digital Aviation Units to Thoma Bravo in $10.55 Billion Deal
Apr 22, 2025 by
CPI
Claus-Dieter Ehlermann, Key Figure in EU Antitrust Policy, Dies at 94
Apr 22, 2025 by
CPI
Instagram Co-Founder Claims Zuckerberg Starved It of Resources After Acquisition
Apr 22, 2025 by
CPI
Binance Advises Governments on Crypto Rules and Digital Asset Reserves
Apr 22, 2025 by
CPI
OpenAI Eyes Chrome If DOJ Forces Google to Sell Browser, Exec Testifies
Apr 22, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece